Vanderbilt Kennedy Center

Deep Brain Stimulation for Depression

Last Updated: Monday, July 09, 2012

Principal Investigator: Ronald Salomon, M.D.

Other researchers: Joseph Neimat, MD

Learn more about Research Family Partners

Description

Have you been diagnosed with major depressive disorder?

  • Are you between 21 and 70 years of age?
  • Did you experience your first depressive episode before age 45?
  • Have you tried at least four treatments in your current episode with unsatisfactory results?
  • Medications such as Zoloft®, Prozac®, Lexapro®, Wellbutrin®, Paxil®, Effexor®, Cybalta®, and combinations of these or other medications
  • Psychotherapy, cognitive behavioral therapy (CBT), or other talk therapies
  • Vagus nerve stimulation (VNS) or transcranial magnetic stimulation (TMSor rTMS)
  • Electroconvulsive therapy (ECT)

If you answered yes and are open to considering a surgical option for your depression, you may qualify to participate in a clinical research study evaluating deep brain stimulation to treat severe major depressive disorder (MDD).

The study is investigating whether or not using a deep brain stimulation (DBS) system* to stimulate a structure in the brain known as Brodmann Area 25 is safe and effective for treating depression that is refractory to currently available therapies.

If you would like more information, please visit www.BroadenStudy.com

*Caution: Investigational device. Limited by United States law to investigational use.

Study is sponsored by St. Jude Medical.

Participant Criteria

Adults 21 and 70 years of age who are depressed

Compensation

$100 per visit once enrolled

Visit Requirements

3 to 5 screening visits plus treatment-related visits

Brochure

Download Brochure

Contact Information

Jared Meggs, MS
(615) 343-5949
jared.meggs@vanderbilt.edu

Want to Participate in this Study?

Enter your name and contact information and this study's coordinators will contact you if there are openings available.

 
 
(Optional)